Home » Topics » BioWorld Science

BioWorld Science
RSS

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 4, 2021

Keaise Medicine patents TRXR inhibitors

Nov. 4, 2021

Novel theranostic agent shows potential for immune-PET imaging and TRT in models of gliomas

Nov. 4, 2021

New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome

Nov. 4, 2021

ADA2-mediated signaling promotes liver fibrosis in NAFLD

Nov. 4, 2021

Colchicine shows promise in a rimmed vacuolar myopathy model

Nov. 4, 2021

WDR5 degrader MS-67 shows promise against AML in murine model

Nov. 4, 2021

Bicycle Therapeutics targets nectin-4 and CD137 with BT-7480

Nov. 4, 2021

New treatment targets identified in opiate abstinence

Nov. 3, 2021

Structure-based optimization identifies potent galactokinase inhibitors

Nov. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...